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GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN 
A CONJUGAL PAIR 
DENNIS D. HICKS’I’EIN, ‘THOMAS R. GRAVELYN, and MELINDA WHAKTON 
Despite the description of 12 pairs of first 
degree relatives with giant cell arteritis and polymyal- 
gia rheumatica, including affected siblings, the occur- 
rence of these two entities in a conjugal pair has not 
been described. Previous reports of familial aggrega- 
tion in giant cell arteritis and polymyalgia rheumatica 
have emphasized a genetic predisposition. A recent 
extensive review of giant cell arteritis by Healey and 
Wilske states: “The strongest factor against an envi- 
ronmental or contagious etiology is that the two syn- 
dromes have not been reported to occur in conjugal 
pairs ( I ) . ”  
In this brief report, we describe polymyalgia 
rheumatica and giant cell arteritis in a husband and 
wife and discuss possible modes of horizontal trans- 
mission. 
Patients. In September 1973, a 74-year-old 
housewife was seen at the Internal Medicine Clinic at 
the University of Michigan Hospital with a 6-month 
history of proximal muscle weakness, bitemporal 
scalp pain, and daily fevers to 101°F. Because of her 
weakness in climbing stairs, a ramp had to be con- 
structed to enable her to ascend the five steps to her 
home. 
Several months before evaluation in our clinic, 
she had experienced a dramatic symptomatic response 
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to an empiric course of steroids. However, she re- 
lapsed when the dose was tapered. 
Extreme tenderness over both temporal arteries 
and marked proximal muscle weakness were noted on 
examination. While receiving 2.5 mg prednisone twice 
a day, her Westergren sedimentation rate was 92 mm/ 
hour. 
In view of her classic history and previous 
response to steroid therapy, a clinical diagnosis of 
giant cell arteritis and polymyalgia rheumatica was 
made. An increase in prednisone to 10 mg/day led to 
improvement in her symptoms and decline in the 
Westergren sedimentation rate to 45 mm/hour. 
During the ensuing 4 years she continued to 
experience mild muscle weakness and fatigue; sup- 
pressive treatment with steroids was hampered by 
gastrointestinal side-effects. She died from intestinal 
perforation in 1977, 4 years after her diagnosis. 
Throughout the illness, her husband remained a 
constant companion. The husband, a retired entrepre- 
neur and former boatman on the Taquamenon River, 
was 71 years old at the time of his wife’s diagnosis in 
1973. They had married 3 years earlier. The marriage, 
the second for both partners, had followed a short 
courtship. They had sexual relations during the 3 years 
of marriage prior to the wife’s diagnosis in 1973 and 
during the 4 years of her illness. Throughout this 
period, the husband remained active and healthy. 
In August 1980, 4 years after his wife’s death, 
the husband was seen at the University of Michigan 
Hospital with a 9-month history of marked fatigue, 
proximal muscle weakness, intense bitemporal scalp 
pain, and daily fevers to 100-102°F. Because of weak- 
ness climbing stairs, he had begun entering his house 
on the ramp constructed for his wife during her illness. 
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On examination, moderate tenderness to palpa- 
tion over the temporal regions was present. Marked 
proximal muscle pain and weakness were demonstrat- 
ed in both upper and lower extremities. His Wester- 
gren sedimentation rate was 119 mm/hour, and both 
SGOT and SGPT were four times the upper limit of 
normal. Temporal artery biopsy showed marked dis- 
ruption of the internal elastic lamina membrane and 
infiltration with giant cells (Figure 1). One day after 
starting prednisone 60 mdday, he was ambulatory 
without difficulty for the first time in 6 months. On a 
current dose of prednisone 20 mglday he continues to 
do well. 
Discussion. The incidence and prevalence of 
giant cell arteritis in the general population vary wide- 
ly. In an analysis from Olmstead County, Minnesota, 
Huston et al found a prevalence of 133 cases per 
100,000 population aged 50 years and older ( 2 ) .  Thus, 
the chance occurrence in a second individual, assum- 
ing its presence in the first, approximates 1 per 1.000. 
Despite this statistical possibility, giant cell arteritis 
has not been reported in close associates, including 
conjugal pairs unrelated by blood. 
Family aggregation of giant cell arteritis and 
polymyalgia rheumatica is well described. Sibling 
pairs have predominated in the literature, with Barber 
noting 2 sisters who developed polymyalgia rheuma- 
tics within 5 years of one another (3) and Hamrin 
reporting 2 sister pairs and 2 sister-brother combina- 
tions with “polymyalgia arteritica” among his 93 cases 
(4). Most sibships had the onset of disease separated 
by 4 or more years. Moreover, family members in all 
of the studies failed to show a common household at 
the time of diagnosis, and all had only casual contact 
with one another. 
A review of 24 consecutive patients with poly- 
myalgia rheumatica and giant cell arteritis at the 
University of Michigan Hospital during the last 8 years 
Failed to demonstrate any familial aggregation or any 
additional conjugal pairs. 
Previous reports of polymyalgia rheumatica and 
giant cell arteritis emphasized possible genetic inheri- 
tance patterns. However, attempts to relate these 
clinical entities to any genotype. including HLA tissue 
typing, have been unsuccessful ( 5 ) .  
The conjugal pair with giant cell arteritis and 
polymyalgia rheumatica in this report suggests a possi- 
ble etiology by exposure to a common antigen or 
Figure 1. Section of temporal artery from the husband demonstrating disruption of media. absence of 
internal elastic membrane, and prominent multinuclear giant cell. (Hematoxylin and eosin; magnification 
X45. )  
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transmission of a causative agent since they had 
intimate contact with one another for the 7 years of 
their marriage. 
An infective etiology for the two illnesses has 
been sought, including a report of exposure to para- 
keets by Fessel, but this was not substantiated by 
further investigators ( 6 ) .  Mowat and Hazelman, in a 
series of 17 patients with polymyalgia rheumatica and 
giant cell arteritis, were unable to demonstrate persis- 
tent elevation of antiviral antibody titers including 
those to rubeola, cytomegalovirus, herpes zoster, her- 
pes simplex, and rubella (7). Finally, a strong associa- 
tion between antibody to hepatitis B surface antigen 
and polymyalgia rheumatica was noted by Bacon et al 
(8). However, a specific indicator of more recent 
exposure to the hepatitis virus, hepatitis B surface 
antigen, was not detected in the sera of any of their 13 
patients. The husband in this report had an elevation in 
SGOT and SGPT four times normal, a well-described 
event in giant cell arteritis; however, his sera did not 
contain hepatitis B antigen or antibody. 
This is the first reported occurrence of giant 
cell arteritis and polymyalgia in a conjugal pair. Al- 
though evidence of horizontal transmission or expo- 
sure to a common source antigen remain speculative, 
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